Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-12580.26%
operating margin TTM
-14116.05%
revenue TTM
1.87 Million
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -1.71 |
| peg ratio | 0.16 |
| price to book ratio | 0.75 |
| price to sales ratio | 215.24 |
| enterprise value multiple | -1.94 |
| price fair value | 0.75 |
profitability ratios | |
|---|---|
| gross profit margin | -166.35% |
| operating profit margin | -14116.05% |
| pretax profit margin | -12890.73% |
| net profit margin | -12580.26% |
| return on assets | -35.89% |
| return on equity | -39.07% |
| return on capital employed | -43.29% |
liquidity ratios | |
|---|---|
| current ratio | 8.66 |
| quick ratio | 8.66 |
| cash ratio | 1.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 77.69 |
| days of payables outstanding | 2,109.83 |
| cash conversion cycle | -2,032.14 |
| receivables turnover | 4.70 |
| payables turnover | 0.17 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | -496.72 |
| cash flow to debt ratio | -23.64 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.40 |
| cash per share | 2.34 |
| operating cash flow per share | -1.05 |
| free cash flow operating cash flow ratio | 1.33 |
| cash flow coverage ratios | -23.64 |
| short term coverage ratios | -1,423.84 |
| capital expenditure coverage ratio | -3.00 |
Frequently Asked Questions
When was the last time Perspective Therapeutics, Inc. (AMEX:CATX) reported earnings?
Perspective Therapeutics, Inc. (CATX) published its most recent earnings results on 10-11-2025.
What is Perspective Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Perspective Therapeutics, Inc. (AMEX:CATX)'s trailing twelve months ROE is -39.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Perspective Therapeutics, Inc. (CATX) currently has a ROA of -35.89%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CATX's net profit margin stand at?
CATX reported a profit margin of -12580.26% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CATX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.66 in the most recent quarter. The quick ratio stood at 8.66, with a Debt/Eq ratio of 0.01.